At a glance
- Originator Mitsubishi Pharma Corporation
- Class Antihyperlipidaemics; Benzofurans
- Mechanism of Action Sterol esterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypercholesterolaemia
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 08 Sep 1998 No-Development-Reported for Hypercholesterolaemia in Japan (Unknown route)
- 29 Aug 1996 New profile